MedTrace Logo

Modulation of Microbial Composition in Ileostomy Patients

NCT02920294 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2018-08-02

No results posted yet for this study

Summary

To determine the small intestinal microbiota response in humans to dietary interventions for two consecutive weeks, and to relate this to parameters of intestinal barrier function and immune and metabolic responses in blood, as functional outcome parameters of host physiology

Conditions

  • Ileostomy - Stoma

Interventions

DIETARY_SUPPLEMENT

Probiotic 1

Fresh fermented dairy drink containing yoghurt ferments

DIETARY_SUPPLEMENT

Probiotic 2

Fresh fermented dairy drink containing probiotic strain

DIETARY_SUPPLEMENT

Placebo

Acidified dairy drink without ferments

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Fred Troost, PhD · Maastricht University Medical Center (MUMC+)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-11-11
Completion
2017-11-11

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02920294 on ClinicalTrials.gov